KeyBanc Capital Markets initiated coverage on BrightSpring Health Services
$BTSG
Medical/Nursing Services
Health Care
KeyBanc Capital Markets initiated coverage of BrightSpring Health Services with a rating of Sector Weight
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/23/2025 | $37.00 | Buy | TD Cowen |
| 12/12/2024 | Market Outperform | CJS Securities | |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 6/21/2024 | $15.00 | Buy | BTIG Research |
| 3/6/2024 | $13.00 | Buy | HSBC Securities |
| 2/27/2024 | $11.50 | Hold → Buy | Deutsche Bank |
| 2/20/2024 | $15.00 | Buy | Guggenheim |
| 2/20/2024 | $15.00 | Outperform | Leerink Partners |
SCHEDULE 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference ca
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) is proud to announce that its specialty pharmacy, Onco360®, has been selected as the national pharmacy partner for several newly approved therapies in the treatment of advanced cancers and rare genetic disorders. Onco360® will help provide access, education, data, and expert support for innovative treatments for patients diagnosed with advanced ovarian and lung cancers, as well as neurofibromatosis type 1. "At Onco360®, we continue to partner with innovators and manufacturers to deliver groundbreaking medicines and therapies to patients faci
LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the "Selling Stockholders"), including affiliates of Kohlberg Kravis Roberts & Co. L.P. (the "KKR Selling Stockholder") and certain members of management, of an aggregate 14,000,000 shares of common stock of BrightSpring pursuant to a shelf registration statement filed by BrightSpring with the U.S. Securities and Exchange Commission (the "SEC"), at the
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
3 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
TD Cowen initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $37.00
CJS Securities initiated coverage of BrightSpring Health Services with a rating of Market Outperform
KeyBanc Capital Markets initiated coverage of BrightSpring Health Services with a rating of Sector Weight
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board's Audit Committee and as the chair of the Board's Quality & Compliance and Governance Committee. As a nationally recognized advocate for greater access, affordability, and excellence in healthcare, Dr. Miller brings decades of experience to the Company as a medical researcher, clinician, and administrator across numerous hea
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company's total Board of Directors to seven members, including two independent directors. Mr. Wicks brings over 20 years of executive leadership experience in the healthcare industry to BrightSpring's Board of Directors, including his most recent role as Executive Vice President
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference ca
LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference call.
LOUISVILLE, Ky., Feb. 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to th
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)